| Oprea, Tudor I; Bologa, Cristian G; Brunak, Søren et al. (2018) Unexplored therapeutic opportunities in the human genome. Nat Rev Drug Discov 17:377 |
| Collins, Kyla A L; Stuhlmiller, Timothy J; Zawistowski, Jon S et al. (2018) Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer. Oncotarget 9:15480-15497 |
| Oprea, Tudor I; Bologa, Cristian G; Brunak, Søren et al. (2018) Unexplored therapeutic opportunities in the human genome. Nat Rev Drug Discov 17:317-332 |
| Sinha, Swati; Eisenhaber, Birgit; Jensen, Lars Juhl et al. (2018) Darkness in the Human Gene and Protein Function Space: Widely Modest or Absent Illumination by the Life Science Literature and the Trend for Fewer Protein Function Discoveries Since 2000. Proteomics 18:e1800093 |
| Stathias, Vasileios; Jermakowicz, Anna M; Maloof, Marie E et al. (2018) Drug and disease signature integration identifies synergistic combinations in glioblastoma. Nat Commun 9:5315 |
| Lin, Yu; Mehta, Saurabh; Küçük-McGinty, Hande et al. (2017) Drug target ontology to classify and integrate drug discovery data. J Biomed Semantics 8:50 |
| Cannon, Daniel C; Yang, Jeremy J; Mathias, Stephen L et al. (2017) TIN-X: target importance and novelty explorer. Bioinformatics 33:2601-2603 |
| Ursu, Oleg; Holmes, Jayme; Knockel, Jeffrey et al. (2017) DrugCentral: online drug compendium. Nucleic Acids Res 45:D932-D939 |
| Nguyen, Dac-Trung; Mathias, Stephen; Bologa, Cristian et al. (2017) Pharos: Collating protein information to shed light on the druggable genome. Nucleic Acids Res 45:D995-D1002 |
| Nelson, Stuart J; Oprea, Tudor I; Ursu, Oleg et al. (2017) Formalizing drug indications on the road to therapeutic intent. J Am Med Inform Assoc 24:1169-1172 |
Showing the most recent 10 out of 20 publications
